Halozyme Therapeutics, Inc. HALO

$128.11 -2.14% at last close

Financials (TTM)

Trailing-twelve-month financial statements are not available for Halozyme Therapeutics, Inc. (HALO) — this is common for ETFs and funds, which report holdings rather than income statements. See the overview page for price history and key stats.

Key Stats

Last Close
$128.11
Market Cap
$14.86 billion
52-Week Range
$61.23 – $134.00
Average Volume
2.32 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.